drug

ibritumomab tiuxetan

Marketedupdated 3mo ago

by Acrotech Biopharma Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying ibritumomab tiuxetan

phase2Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantationcompletedn=26
phase4Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphomacompletedn=12

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 4m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

ibritumomab tiuxetan

Marketedupdated 3mo ago

by Acrotech Biopharma Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying ibritumomab tiuxetan

phase2Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantationcompletedn=26
phase4Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphomacompletedn=12

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 4m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

ibritumomab tiuxetan

all catalysts(0)

Trials studying ibritumomab tiuxetan

News(0)

Report a data issue

comments(0)

ibritumomab tiuxetan

all catalysts(0)

Trials studying ibritumomab tiuxetan

News(0)

Report a data issue

comments(0)